Abstract
Real-time measurements of second messengers in living cells, such as cAMP, are usually performed by ratiometric fluorescence resonance energy transfer (FRET) imaging. However, correct calibration of FRET ratios, accurate calculations of absolute cAMP levels and actual permeabilities of different cAMP analogs have been challenging. Here we present a protocol that allows precise measurements of cAMP concentrations and kinetics by expressing FRET-based cAMP sensors in cells and modulating them with an inhibitor of adenylyl cyclase activity and a cell-permeable cAMP analog that fully inhibits and activates the sensors, respectively. Using this protocol, we observed different basal cAMP levels in primary mouse cardiomyocytes, thyroid cells and in 293A cells. The protocol can be generally applied for calibration of second messenger or metabolite concentrations measured by FRET, and for studying kinetics and pharmacological properties of their membrane-permeable analogs. The complete procedure, including cell preparation and FRET measurements, takes 3–6 d.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
How Carvedilol activates β2-adrenoceptors
Nature Communications Open Access 19 November 2022
-
A high-performance genetically encoded fluorescent indicator for in vivo cAMP imaging
Nature Communications Open Access 12 September 2022
-
RGS3L allows for an M2 muscarinic receptor-mediated RhoA-dependent inotropy in cardiomyocytes
Basic Research in Cardiology Open Access 01 March 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout



References
Beavo, J.A. & Brunton, L.L. Cyclic nucleotide research—still expanding after half a century. Nat. Rev. Mol. Cell Biol. 3, 710–718 (2002).
Förster, T. Zwischenmolekulare Energiewanderung und Fluoreszenz. Ann. Physik. 437, 55–75 (1948).
Stryer, L. Fluorescence energy transfer as a spectroscopic ruler. Annu. Rev. Biochem. 47, 819–846 (1978).
Zhang, J., Campbell, R.E., Ting, A.Y. & Tsien, R.Y. Creating new fluorescent probes for cell biology. Nat. Rev. Mol. Cell Biol. 3, 906–918 (2002).
Miyawaki, A. Visualization of the spatial and temporal dynamics of intracellular signaling. Dev. Cell 4, 295–305 (2003).
Lohse, M.J. et al. Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors. Trends Pharmacol. Sci. 29, 159–165 (2008).
Nikolaev, V.O. & Lohse, M.J. Monitoring of cAMP synthesis and degradation in living cells. Physiology (Bethesda) 21, 86–92 (2006).
Berrera, M. et al. A toolkit for real-time detection of cAMP: insights into compartmentalized signaling. Handb. Exp. Pharmacol. 186, 285–298 (2008).
Willoughby, D. & Cooper, D.M. Live-cell imaging of cAMP dynamics. Nat. Methods 5, 29–36 (2008).
Zaccolo, M. & Pozzan, T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295, 1711–1715 (2002).
DiPilato, L.M., Cheng, X. & Zhang, J. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc. Natl. Acad. Sci. USA 101, 16513–16518 (2004).
Ponsioen, B. et al. Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep. 5, 1176–1180 (2004).
Nikolaev, V.O., Bünemann, M., Hein, L., Hannawacker, A. & Lohse, M.J. Novel single chain cAMP sensors for receptor-induced signal propagation. J. Biol. Chem. 279, 37215–37218 (2004).
Nikolaev, V.O., Bünemann, M., Schmitteckert, E., Lohse, M.J. & Engelhardt, S. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling. Circ. Res. 99, 1084–1091 (2006).
Brooker, G., Harper, J.F., Terasaki, W.L. & Moylan, R.D. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic. Nucleotide Res. 10, 1–33 (1979).
Williams, C. cAMP detection methods in HTS: selecting the best from the rest. Nat. Rev. Drug Discov. 3, 125–135 (2004).
Lehnart, S.E. et al. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 123, 25–35 (2005).
Lefkimmiatis, K., Moyer, M.P., Curci, S. & Hofer, A.M. 'cAMP sponge': a buffer for cyclic adenosine 3′, 5′-monophosphate. PLoS ONE 4, e7649 (2009).
Norris, R.P. et al. Cyclic GMP from the surrounding somatic cells regulates cyclic AMP and meiosis in the mouse oocyte. Development 136, 1869–1878 (2009).
Mironov, S.L. et al. Imaging cytoplasmic cAMP in mouse brainstem neurons. BMC Neurosci. 10, 29 (2009).
Leroy, J. et al. Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases. Circ. Res. 102, 1091–1100 (2008).
Iancu, R.V. et al. Cytoplasmic cAMP concentrations in intact cardiac myocytes. Am. J. Physiol. Cell Physiol. 295, C414–C422 (2008).
Nikolaev, V.O. et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327, 1653–1657 (2010).
von Hayn, K. et al. Gq-mediated Ca2+ signals inhibit adenylyl cyclases 5/6 in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 298, C324–C332 (2010).
Jacobs, S., Calebiro, D., Nikolaev, V.O., Lohse, M.J. & Schulz, S. Real-time monitoring of somatostatin receptor-cAMP signaling in live pituitary. Endocrinology 151, 4560–4565 (2010).
Calebiro, D. et al. Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. PLoS Biol. 7, e1000172 (2009).
Aoki, K. & Matsuda, M. Visualization of small GTPase activity with fluorescence resonance energy transfer-based biosensors. Nat. Protoc. 4, 1623–1631 (2009).
Palmer, A.E. & Tsien, R.Y. Measuring calcium signaling using genetically targetable fluorescent indicators. Nat. Protoc. 1, 1057–1065 (2006).
Werthmann, R.C., von Hayn, K., Nikolaev, V.O., Lohse, M.J. & Bünemann, M. Real-time monitoring of cAMP levels in living endothelial cells: thrombin transiently inhibits adenylyl cyclase 6. J. Physiol. 587, 4091–4104 (2009).
Nikolaev, V.O., Gambaryan, S., Engelhardt, S., Walter, U. & Lohse, M.J. Real-time monitoring of the PDE2 activity of live cells: hormone-stimulated cAMP hydrolysis is faster than hormone-stimulated cAMP synthesis. J. Biol. Chem. 280, 1716–1719 (2005).
Lissandron, V. et al. Transgenic fruit-flies expressing a FRET-based sensor for in vivo imaging of cAMP dynamics. Cell Signal. 19, 2296–2303 (2007).
Shafer, O.T. et al. Widespread receptivity to neuropeptide PDF throughout the neuronal circadian clock network of Drosophila revealed by real-time cyclic AMP imaging. Neuron 58, 223–237 (2008).
Di Benedetto, G. et al. Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ. Res. 103, 836–844 (2008).
Willemse, M., Janssen, E., de Lange, F., Wieringa, B. & Fransen, J. ATP and FRET—a cautionary note. Nat. Biotechnol. 25, 170–172 (2007).
Wachten, S. et al. Distinct pools of cAMP centre on different isoforms of adenylyl cyclase in pituitary-derived GH3B6 cells. J. Cell Sci. 123, 95–106 (2010).
Kawasaki, H. et al. A family of cAMP-binding proteins that directly activate Rap1. Science 282, 2275–2279 (1998).
Mei, F.C. et al. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J. Biol. Chem. 277, 11497–11504 (2002).
Bartsch, M. et al. Bioactivatable, membrane-permeant analogs of cyclic nucleotides as biological tools for growth control of C6 glioma cells. Biol. Chem. 384, 1321–1326 (2003).
Schultz, C. et al. Acetoxymethyl esters of phosphates, enhancement of the permeability and potency of cAMP. J. Biol. Chem. 268, 6316–6322 (1993).
Xia, Z. & Liu, Y. Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes. Biophys. J. 81, 2395–2402 (2001).
Acknowledgements
The work in authors' laboratories is supported by the Deutsche Forschungsgemeinschaft (grants SFB487 and SFB688 to M.J.L.; grant NI 1301/1-1 to V.O.N.), European Research Council (to M.J.L.) and University of Göttingen Medical Center ('pro futura' grant to V.O.N.). We thank H.-G. Genieser for critical reading of the manuscript.
Author information
Authors and Affiliations
Contributions
S.B., F.S., F.B. and V.O.N. performed experiments and analyzed the data. A.S. and D.C. prepared primary cardiomyocytes and thyroid cells. F.S., M.J.L. and V.O.N. developed the protocol. S.B. and V.O.N. wrote the paper.
Corresponding author
Ethics declarations
Competing interests
F.S. is an employee and a shareholder of the Biolog Life Science Institute, a company that sells chemicals including cAMP analogs.
Supplementary information
Supplementary Figure 1
Experiments aimed to determine the concentration of MDL-12,330A which is capable of fully inhibiting adenylyl cyclase activity in cells and which can be used to reliably measure Rmin values. (PDF 56 kb)
(a) Concentration-response dependence of MDL-12,330A effect on the basal FRET ratio in cardiomyocytes shows that 100 µM of this compound can fully inhibit the sensor, and application of higher inhibitor concentrations does not lead to lower Rmin values (means ± SEM, n=7), which was also true for thyroid cells (not shown). (b) In cells with low basal adenylyl cyclase activity, inhibitory effect of MDL-12,330A can be tested after stimulation of cAMP production, as shown here for 293A cells treated with the _-adrenergic receptor agonist isoproterenol. 100 µM of MDL-12,330A were also sufficient to fully block the stimulated adenylyl cyclase activity in these cells. A grey trace shows a control experiment where the buffer A was added instead of MDL-12,330A, which did not result in a rapid decrease of signal. Representative experiments, n=5.
Rights and permissions
About this article
Cite this article
Börner, S., Schwede, F., Schlipp, A. et al. FRET measurements of intracellular cAMP concentrations and cAMP analog permeability in intact cells. Nat Protoc 6, 427–438 (2011). https://doi.org/10.1038/nprot.2010.198
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2010.198
This article is cited by
-
RGS3L allows for an M2 muscarinic receptor-mediated RhoA-dependent inotropy in cardiomyocytes
Basic Research in Cardiology (2022)
-
How Carvedilol activates β2-adrenoceptors
Nature Communications (2022)
-
A high-performance genetically encoded fluorescent indicator for in vivo cAMP imaging
Nature Communications (2022)
-
Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation
Naunyn-Schmiedeberg's Archives of Pharmacology (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.